# A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

> **NCT00560404** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 233 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]
- **DRUG:** Epoetin alfa

## Key facts

- **NCT ID:** NCT00560404
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560404, "A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00560404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*